Literature DB >> 8731170

Memantine reduces functional and morphological consequences induced by global ischemia in rats.

F Block1, M Schwarz.   

Abstract

In this study the effect of memantine, an antagonist at the N-methyl-D-aspartate receptor, on spatial learning deficit and on neuronal damage following transient cerebral ischemia was evaluated. Global ischemia was induced by four-vessel-occlusion (4VO) for 20 min in rats. Memantine was administered 20 min before induction of ischemia at a dose of 10 or 20 mg/kg. One week after surgery spatial learning was tested in the Morris water maze. Treatment with the higher dose of memantine reduced the increase in escape latency and in swim distance induced by 4VO. Neuronal damage in the CA1 sector of the hippocampus and in the striatum produced by 4VO was significantly attenuated by 20 mg/kg memantine. Treatment with the lower dose of memantine had no influence on the deficit in spatial learning and the neuronal damage resulting from ischemia. The present data demonstrate that treatment with a neuroprotective agent like memantine can reduce functional as well as morphological sequelae induced by ischemia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8731170     DOI: 10.1016/0304-3940(96)12545-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  10 in total

1.  Pharmacologic amelioration of severe hypoglycemia-induced neuronal damage.

Authors:  Julie M Silverstein; Daniel Musikantow; Erwin C Puente; Dorit Daphna-Iken; Adam J Bree; Simon J Fisher
Journal:  Neurosci Lett       Date:  2011-01-25       Impact factor: 3.046

2.  Memantine alleviates brain injury and neurobehavioral deficits after experimental subarachnoid hemorrhage.

Authors:  Chih-Yuan Huang; Liang-Chao Wang; Hao-Kuang Wang; Chia-Hsin Pan; Ya-Yun Cheng; Yan-Shen Shan; Chung-Ching Chio; Kuen-Jer Tsai
Journal:  Mol Neurobiol       Date:  2014-06-22       Impact factor: 5.590

3.  Both the neuronal and inducible isoforms contribute to upregulation of retinal nitric oxide synthase activity by brain-derived neurotrophic factor.

Authors:  N Klöcker; P Kermer; M Gleichmann; M Weller; M Bähr
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

4.  The effects of memantine on lipid peroxidation following closed-head trauma in rats.

Authors:  Hakan Ozsüer; Aşkin Görgülü; Talat Kiriş; Sabahattin Cobanoğlu
Journal:  Neurosurg Rev       Date:  2005-01-26       Impact factor: 3.042

Review 5.  Glutamate receptors, neurotoxicity and neurodegeneration.

Authors:  Anthony Lau; Michael Tymianski
Journal:  Pflugers Arch       Date:  2010-03-14       Impact factor: 3.657

6.  Combination of HBO and Memantine in Focal Cerebral Ischemia: Is There a Synergistic Effect?

Authors:  Feng Wang; Wei Liang; Chong Lei; Renee Kinden; Hanfei Sang; Yaning Xie; Yi Huang; Yan Qu; Lize Xiong
Journal:  Mol Neurobiol       Date:  2014-10-30       Impact factor: 5.590

7.  NMDA receptor blockade with memantine attenuates white matter injury in a rat model of periventricular leukomalacia.

Authors:  Simon M Manning; Delia M Talos; Chengwen Zhou; Debra B Selip; Hyun-Kyung Park; Chang-Joo Park; Joseph J Volpe; Frances E Jensen
Journal:  J Neurosci       Date:  2008-06-25       Impact factor: 6.167

8.  The dichotomy of memantine treatment for ischemic stroke: dose-dependent protective and detrimental effects.

Authors:  Melissa Trotman; Philipp Vermehren; Claire L Gibson; Robert Fern
Journal:  J Cereb Blood Flow Metab       Date:  2014-11-19       Impact factor: 6.200

Review 9.  Targeting Sentinel Proteins and Extrasynaptic Glutamate Receptors: a Therapeutic Strategy for Preventing the Effects Elicited by Perinatal Asphyxia?

Authors:  Mario Herrera-Marschitz; Ronald Perez-Lobos; Carolyne Lespay-Rebolledo; Andrea Tapia-Bustos; Emmanuel Casanova-Ortiz; Paola Morales; Jose-Luis Valdes; Diego Bustamante; Bruce K Cassels
Journal:  Neurotox Res       Date:  2017-08-26       Impact factor: 3.911

10.  Clavulanic Acid: A Novel Potential Agent in Prevention and Treatment of Scopolamine-Induced Alzheimer's Disease.

Authors:  Mahdieh Anoush; Zeinab Pourmansouri; Rafi Javadi; Benyamin GhorbanPour; Ali Sharafi; Hamed Mohamadpour; Iraj Jafari Anarkooli; Sina Andalib
Journal:  ACS Omega       Date:  2022-04-13
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.